Global Zika Virus Testing Market

Global Zika Virus Testing Market was valued at USD 261.38 Mn in 2025 and is expected to reach USD 445.02 Mn by 2032, growing at a CAGR of 7.9% during the forecast period.

Zika Virus Testing Market Overview:

The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. Currently, there is no treatment or vaccine to protect specifically against Zika virus infection. In April 2017, CDC reported that 5,264 people were infected with Zika in the U.S., where more than 1,700 pregnant women were found Zika-positive and 58 babies were born with birth defects.

To Know About The Research Methodology :- Request Free Sample Report

Zika Virus Testing Market Dynamics:

Demand for Point-of-care Diagnostics test results in rapid growth of market.

According to the World Health Organization (WHO), about 84 countries are previously infected by ZIKV transmission. Thus, the rising prevalence of Zika virus infection primarily drives the market growth. Tests like RT-PCR, ELISA, which can be performed without any laboratory setup are considered POCT tests. Preference for ELISA test as point-of-care testing for Zika virus, due to its specificity and sensitivity. Initiatives are undertaken by the government for the development of innovative tests capable to detect the Zika virus, growing awareness about early detection of the disease, and ongoing research and development activities fuel the market growth. Despite the technological advancements being introduced, the slow adoption of these technologies in some developing countries due to the high cost associated with them may impact negatively on the market growth.

The report has profiled key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed.

Zika Virus Testing Market Segment Analysis:

In 2025, the Test Type segment shows the highest demand for Nucleic Acid Amplification Tests (NAAT), particularly RT-PCR-based assays. Molecular testing remains critical for early and accurate detection of Zika virus infection, especially during the acute phase, due to its high sensitivity and specificity. These tests are widely preferred in hospitals and diagnostic laboratories for confirming active infections.

Serologic Tests, including IgM and IgG antibody-based assays, continue to be important, particularly for identifying past infections and in regions with limited molecular testing infrastructure. While Rapid/Point-of-Care tests are gaining traction in outbreak-prone and resource-limited settings due to ease of use and quick turnaround time, they do not yet match the diagnostic accuracy and demand levels of molecular testing platforms. Overall, molecular diagnostics remain the dominant and most strategically significant segment in 2025.

Based on End User, Diagnostic Laboratories represent the most demanded segment in 2025. These laboratories handle large volumes of confirmatory testing and are equipped with advanced molecular diagnostic platforms, making them central to Zika virus detection and surveillance programs.

Hospitals and Clinics also account for substantial demand, particularly for prenatal screening of pregnant women and symptomatic patient testing. Public Health Agencies play a crucial role during outbreak situations, driving demand through government-led surveillance and screening initiatives. Research Institutes and Blood Banks contribute moderately to the market, mainly for epidemiological studies and blood safety screening. Overall, diagnostic laboratories remain the primary revenue-generating end-user segment.

Zika Virus Testing Market Regional Insights:

Based on Region, North America leads the global Zika Virus Testing Market in 2025, supported by advanced diagnostic infrastructure, strong public health surveillance systems, and high awareness regarding vector-borne diseases. The presence of established diagnostic companies and regulatory support further strengthens regional dominance.

Latin America shows significant demand due to historical outbreaks and continued monitoring efforts in countries prone to mosquito-borne infections. Asia Pacific is witnessing steady growth driven by improving healthcare infrastructure, rising awareness, and increasing investment in infectious disease diagnostics. Europe demonstrates moderate demand, largely focused on travel-related testing and preventive surveillance. Meanwhile, the Middle East & Africa region shows gradual growth, influenced by expanding healthcare access and emerging disease monitoring programs.

The report also helps in understanding global market dynamics, structure by analyzing the market segments and projects the global market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global market make the report investor’s guide.

Zika Virus Testing Market Scope: Inquire before buying

Zika Virus Testing Market, By Region:

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Key Players /Competitor Profiles Covered in the Global Zika Virus Testing Market Report from a Strategic Perspective.

1. Roche Diagnostics
2. Thermo Fisher Scientific
3. Abbott Laboratories
4. QIAGEN
5. bioMérieux
6. Siemens Healthineers
7. Hologic
8. PerkinElmer
9. Cepheid
10. Quest Diagnostics
11. Meridian Bioscience
12. Bio Rad Laboratories
13. GenBody
14. Euroimmun
15. ELITechGroup
16. Altona Diagnostics
17. DiaSorin
18. Novacyt
19. Co Diagnostics
20. Biocan Diagnostics
21. SD Biosensor
22. ARUP Laboratories
23. Viatris
24. Genekam
25. Creative Diagnostics